`
`Sent:
`
`To:
`
`Mon Jun 05 2006 08:09:21 EDT
`
`alfred sandrock/cambridge/biogen@
`
`
`
`
`
`;carmen bozic/cambridge/biogen@biogenidec;
`
`;gilmore o'neill/cambridge/biogen@biogenidec;
`
`
`
`
`
`
`
`
`
`;minhua
`
`yang/cambridge/biogen@biogenidec;
`
`
`;ratna lingamaneni/cambridge/biogen@biogenidec;tammy
`sarnelli/cambridge/biogen@biogenidec;
`
`Subject:
`
`Information Update - There are multiple changes: BG12 MS MOCK regulatory authority meeting
`(rehearsal)
`
`Dear All,
`
`The BG12 MS team are preparing for scientific advice meetings (National meetings are planned
`with Sweden, Netherlands and UK). In order to facilitate the preparation for these meetings the
`team would value a practice mock Agency meeting with senior management taking on the role of
`the Agency
`
`I would therefore value your input at this meeting, although I appreciate that this timeslot will
`not be suitable for everyone
`
`Page 1 of 2
`
`Biogen Exhibit 2351
`Coalition v. Biogen
`IPR2015-01993
`
`
`
`Gilmore will present for 15 minutes and then the panel will have the opportunity to ask him and
`the rest of the team questions relating to the BG12 MS development plan.
`
`By way of background please find attached a copy of the planned Agency questions and the
`briefing document
`
`
`
`Room 621 is booked in Cambridge and Dorney in the UK
`Please use the following dial-in details
`Int: (706) 758-0773
`US: (866) 309-3684
`Conference code: 8512592
`Leader pin (Anélie / Adam): 2592
`
`Best regards
`
`Page 2 of 2